Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Overexpression of PTHrP in chondrocytes causes short-limbed dwarfism and delayed bone formation in mice.

Cronkhite-Canada syndrome is rare, has a poor prognosis, and requires early diagnosis and ongoing treatment.

Allopregnanolone is needed for certain brain processing issues caused by D1 dopamine receptor activation.

Clascoterone cream was approved in the USA for treating acne in people aged 12 and older.

CRISPR gene editing reduces harmful molecules in cells from Emery–Dreifuss Muscular Dystrophy patients.

Proretinal nanoparticles are a safe and effective way to deliver retinal to the skin.

A girl had rickets due to a gene mutation affecting vitamin D response.

The protein AtRXR3 limits root hair growth in Arabidopsis, affecting phosphorus uptake.

The P133R mutation in AKR1D1 enzyme causes harmful bile acid buildup, explaining related health issues.

CMC2.24 and CMC2.23 reduce melanin safely and effectively.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Rituximab leads to longer remission and fewer side effects than cyclophosphamide.

The new compound was more effective than finasteride in reducing markers of hair loss and prostate issues in cell tests.

Upadacitinib may effectively treat twenty-nail dystrophy without causing pain.

Catharanthus roseus and Schwenckia americana extracts are generally safe but may cause kidney and liver tissue damage.

Trichorhinophalangeal syndrome causes hair, facial, and bone issues, with no specific treatment beyond gentle care.

Ritlecitinib is safe for treating alopecia areata for up to 48 weeks.

Two patients got Cushing's syndrome after treatment with Triamcinolone Acetonide for mouth fibrosis, but recovered after stopping the treatment.

Propylthiouracil, a thyroid medication, can cause skin blood clots and immune-related blood vessel inflammation.

Serotonin helps wounds heal faster.

Bromhexine and spironolactone together reduced COVID-19 symptoms and hospitalization time without side effects.

Rat hair follicle stem cells have functional oxytocin receptors, useful for studying neuropsychiatric disorders.

New curcumin analogues help fight prostate cancer by breaking down androgen receptors.

Ritlecitinib effectively regrows hair in treatment-resistant alopecia areata with mild side effects.

Ritlecitinib effectively reduces severe hair loss in alopecia areata over 24 months.

Cyproterone acetate with estradiol may subjectively improve excessive hair growth in women, but it's not clinically better than other treatments.

Erlotinib causes skin inflammation through IL-1, which can be reduced by anakinra.

Ritlecitinib helps regrow hair in alopecia areata and is safe for long-term use.

PROTACs show promise for cancer treatment, but designing them effectively is challenging.